Drug recall · April 8, 2020
Glycopyrrolate Tablets recall
Why: Failed Impurities/Degradation Specification: Presence of unknown impurity observed.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01
- Lots / codes
Lot # 32809101, Exp 3/2021
- Quantity
- 29,352 bottles
- Company
- Par Pharmaceutical Inc., Chestnut Ridge, NY
- Distribution
- Product was distributed within the United States.
- Initiated
- March 30, 2020 · Voluntary: Firm initiated
- Classified
- March 30, 2020
- Reported
- April 8, 2020
- Ended
- November 2, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glycopyrronium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.